Navigation Links
First genetically engineered malaria vaccine to enter human trials
Date:7/29/2009

Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease. The vaccine, developed in collaboration with researchers from the US, Japan and Canada, will be trialled in humans from early next year.

Malaria kills more than one million people each year and destroys through premature death and disability the equivalent of at least 35 million years of healthy, productive human life every year.

Professor Alan Cowman, head of the institute's Infection and Immunity division, said in developing the vaccine the research team had deleted two key genes in the Plasmodium falciparum parasite which causes the form of malaria most deadly to humans. By removing the genes the malaria parasite is halted during its liver infection phase, preventing it from spreading to the blood stream where it can cause severe disease and death.

Their success in genetically modifying the parasite and thereby preventing its invasion of red blood cells is published in the current issue of the Proceedings of the National Academy of Sciences USA.

Professor Cowman said similar vaccines had been tested in mice and offered 100 per cent protection against malaria infection. He said it was hoped the vaccine would produce similar results in humans. "Although two genes have been deleted the parasite is still alive and able to stimulate the body's protective immune system to recognize and destroy incoming mosquito-transmitted deadly parasites," Professor Cowman said.

This approach to vaccine development using a weakened form of the whole organism that causes a particular disease has proven successful in eradicating smallpox and controlling diseases such as flu and polio.

Professor Cowman said the research team, which includes Dr Matthew O'Neill and Dr Alex Maier from the institute as well as scientists from the Seattle Biomedical Research Institute, the Walter Ree
'/>"/>

Contact: Penny Fannin
fannin@wehi.edu.au
61-393-452-345
Walter and Eliza Hall Institute
Source:Eurekalert  

Page: 1 2

Related biology technology :

1. First U.K. Stem Cell Awareness Rally to Take Place in Manchester, England on August 9th, 2009
2. RadMD First to Offer CME-Certified Education and Training For Medical Imaging in Clinical Trials
3. GreenHouse Debuts the World's First E-Fuel MicroFuelerTM in Los Angeles
4. FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics Focus Diagnostics Business
5. Surgeon Performs First Single Incision Peri-Umbilical Laparoscopic Surgery in the State of Missouri
6. OpenQ Posts a 200% Revenue Growth in the First Half of 2009
7. Essilor : First Half 2009 Revenue
8. Sumavel(TM) DosePro(TM) (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System
9. China Biologic Products Hosts its First Forum for Strategy and Development
10. First Catalog Cancer Biochip for Sequence Capture Now Available from febit
11. Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
First genetically engineered malaria vaccine to enter human trials
First genetically engineered malaria vaccine to enter human trials
(Date:11/24/2009)..., SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiol...ation(SFDA)hasapprovedthe,investigationalnewdrugap...innovativeinsulinformulationtotreatdiabetes.ThisIN...nicalstudy. , Diabetesisadisordercharacterist...tionsofdiabetesoftenresultinseveremicro-and,macro-...
(Date:11/24/2009)..., DUBLIN,November24/PRNewswire-FirstCall/--Shire...pharmaceuticalcompany,today,announcedthatithassubm...rasealfa,thecompany,senzymereplacementtherapyindev...isthethirdmarketing,applicationforvelaglucerasealf...eUnitedStatesandCanada. , Basedonaglobalsuppl...
(Date:11/24/2009)... Chemical Abstracts Service (...eports that China,s patent office is now the world...ns in chemistry. China trailed Japan,s patent offi...WIPO), and the United States Patent and Trademark ...the USPTO in 2005, WIPO in 2006, and exceeded Japa...
(Date:11/23/2009)...aphene consists of a two-dimensional carbon layer ...nal lattice, resembling a honeycomb. Carbon nanotu...les of graphene sheets form graphite. Graphene boa...mely tear-resistant, an excellent thermal conducto...ittleness and ductility. In addition, graphene is ...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Polymer with honeycomb structure 2
...s, Inc. (the "Company") (Nasdaq: KERX ) announce...ecutive Officer of the Company. It is also anticip...d of Directors at the annual meeting of the board ...Chairman of the Company,s Board of Directors, stat... Bentsur to Keryx. Ron is an experienced biopharm...
...tories, Inc., a leading research-based contract ma...ts to the pharmaceutical industry, with sites in t...nt addition of Dr. Chris Huber as Director of Chem...ble over 15 years experience in the pharmaceutical...ss technology for API manufacturing of small molec...
...gh Growth Brazilian Market for Aesthetic and Medic...thera announced today the receipt of ANVISA cleara...eumatic(TM) based platforms in Brazil. ANVISA (Ag...lian national health surveillance and regulatory a...rket medical devices in Brazil. , , Aesthera also...
Other Biology Technology:Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer 2Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer 3Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer 4Dr. Chris Huber Joins Asymchem Laboratories Inc. as Director of Chemical Development 2Aesthera Announces ANVISA Clearance to Market Photopneumatic Platforms in Brazil 2Aesthera Announces ANVISA Clearance to Market Photopneumatic Platforms in Brazil 3
(Date:11/23/2009)... , Farmington, CT Current research suggests that... disease. The related report by Nichols et al, "U...nt a New Class of TLR2 Ligands Capable of Enhancin...e of The American Journal of Pathology . , Mult...stem attacks the brain and spinal cord, affects ne...
(Date:11/23/2009)... , MADISON, WI, November 16, 2009 -- A USDOE and ... cropland, idle cropland, and cropland pasture cou...n of perennial grasses, such as switchgrass, from ...uel feedstock. Economically viable production of a...l quantities of biomass are removed annually is ex...
(Date:11/23/2009)... , , University of Southern California biomedical...s to develop a new tool to help clinicians disting...ry from chronic problems manageable with drugs and...catheters inserted into the arteries feeding the h... ("lumen") of these blood vessels, often revealing...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Switchgrass produces biomass efficiently 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Maize cell wall genes identified giving boost to biofuel research 10819 1Maize cell wall genes identified giving boost to biofuel research 10819 2Kidney Transplant Sleep Disorder May Add Up to Trouble 61759 1Kidney Transplant Sleep Disorder May Add Up to Trouble 61759 2Appalachia Southeast Hit Hardest by Obesity and Diabetes 61755 1Appalachia Southeast Hit Hardest by Obesity and Diabetes 61755 2Appalachia Southeast Hit Hardest by Obesity and Diabetes 61755 3
...ss journal PLoS Biology, researchers used new ta...sing result that the survival of juvenile salmon i...e the presence of an extensive network of dams in ... follow larger ocean dwellers such as sharks, stur...ns of mature salmon along marine coasts. Now for t...
...abetes may be more likely to keep working if they ...University School of Medicine in St. Louis have fo..., sulfonylureas, help type 2 diabetics make more i...ut in most patients the effects of sulfonylureas a...n secretion to shut down. This typically forces pa...
...nd using alcohol-based hand sanitizers may prevent...nt, a landmark new study suggests. , In a first-...ical interventions in controlling the spread of th... the University of Michigan School of Public Healt...ven U-M residence halls during last year,s flu sea...
Other Biology News:Research challenges conventional notions about salmon survival 2Moderate use averts failure of type 2 diabetes drugs in animal model 2Masks, hand washing, prevent spread of flu-like symptoms by up to 50 percent 2Masks, hand washing, prevent spread of flu-like symptoms by up to 50 percent 3
... pPIC3.5K vectors carry the kanamycin resistance g...n Pichia. Spontaneous generation of multiple inser...reased levels of Geneticin Reagent. Pichia transfo...and screened for their level of resistance to Gene...
Rabbit Anti-WW domain-containing oxidoreductase Antibody, Unconjugated from ABR-Affinity BioReagents
TBS Buffer from Invitrogen
Western Blot from Covance Research Products, Inc
Biology Products: